MSP Logo

Motivated campaign to kill generic industry in India

English

In the backdrop of the Ranbaxy case in the US, Newsclick talks to Dr Amit Sengupta from the Jan Swasthya Abhyan on the situation in the pharmaceutical sector at large. Dr Sengupta says that a motivated campaign, supported by big US pharmaceutical industries, is being orchestrated to kill the Indian generic industry as they see it as a threat to their own markets.

Producer: 
NewsClick
Format: 
Video
Release Date: 
June 16, 2013